Internal medicine in the 21st century: Back to the future.

GĂłmez-Huelgas R, Dalekos GN, Dicker D, Montano N

A new framework for the diagnosis, staging and management of obesity in adults.

Busetto L, Dicker D, FrĂźhbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM, SELECT Trial Investigators

Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure.

Wolff Sagy Y, Lavie G, Ramot N, Battat E, Arbel R, Reges O, Dicker D

A safety evaluation of intermittent high-dose inhaled nitric oxide in viral pneumonia due to COVID-19: a randomised clinical study.

Wolak T, Dicker D, Shifer Y, Grossman A, Rokach A, Shitrit M, Tal A

Assessing the state of obesity care: Quality, access, guidelines, and standards.

Kaplan LM, Apovian CM, Ard JD, Allison DB, Aronne LJ, Batterham RL, Busetto L, Dicker D, Horn DB, Kelly AS, Mechanick JI, Purnell JQ, Ramos-Salas X, Assessing the State of Obesity Care Writing Group

Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.

Ryan DH, Lingvay I, Deanfield J, Kahn SE, Barros E, Burguera B, Colhoun HM, Cercato C, Dicker D, Horn DB, Hovingh GK, Jeppesen OK, Kokkinos A, Lincoff AM, MeyhĂśfer SM, Oral TK, Plutzky J, van Beek AP, Wilding JPH, Kushner RF

Applications to augment patient care for Internal Medicine specialists: a position paper from the EFIM working group on telemedicine, innovative technologies & digital health.

Pietrantonio F, Florczak M, Kuhn S, Kärberg K, Leung T, Said Criado I, Sikorski S, Ruggeri M, Signorini A, Rosiello F, Drago C, Vinci A, Barreto V, Montano N, Dicker D, Gomez Huelgas R

Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality.

Dicker D, Sagy YW, Ramot N, Battat E, Greenland P, Arbel R, Lavie G, Reges O

Association of Waist Circumference and Body Mass Index Deciles Ratio with All-Cause Mortality: Findings from the National Health and Nutrition Examination Survey.

Reges O, Test T, Dicker D, Karpati T

Can Consultation by a Clinical Pharmacist Prevent Morbidity and Mortality in Patients Undergoing Bariatric Surgery?

Azran C, Dahan AE, Shimoni O, Dicker D, Hammerman A, Dahan A

IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study.

Salminen P, Kow L, Aminian A, Kaplan LM, Nimeri A, Prager G, Behrens E, White KP, Shikora S, IFSO Experts Panel

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH, SELECT Trial Investigators

Subcutaneous Semaglutide Use for Weight Management: Practice and Attitudes of Physicians in Israel.

Dicker D, Tamir O, Lieberman-Segal G, Eldor R, Accos-Carmel M, Kolobov T, Karasik A